Zobrazeno 1 - 10
of 402
pro vyhledávání: '"Diamant Thaçi"'
Autor:
Alexander Egeberg, Curdin Conrad, Patricia Gorecki, Sven Wegner, Jozefien Buyze, Lorenzo Acciarri, Diamant Thaçi
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 3, Pp 745-758 (2024)
Abstract Introduction This study aimed to understand treatment response dynamics, including factors associated with favorable response, among patients with moderate-to-severe psoriasis who received guselkumab, adalimumab, or secukinumab. Methods Thes
Externí odkaz:
https://doaj.org/article/0a5c486ff9f94c94afb748251a447719
Autor:
Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaçi, Anja Plenske, Pascal Klaus, Thomas Meng
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 2, Pp 331-348 (2024)
Abstract Introduction For chronic diseases such as axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), and plaque psoriasis (PsO), treatment goals include remission or at least low disease activity (LDA) by 12 weeks. Improvements in symptoms
Externí odkaz:
https://doaj.org/article/b7c4e52911c2482e8a2722cdfebc065f
Autor:
Henning Olbrich, Khalaf Kridin, Gema Hernández, Henner Zirpel, Christian D. Sadik, Patrick Terheyden, Diamant Thaçi, Ralf J. Ludwig, Katharina Boch
Publikováno v:
EBioMedicine, Vol 103, Iss , Pp 105123- (2024)
Summary: Background: Prurigo nodularis (PN) presents with intensely itchy hard nodules. Despite being limited to the skin, PN was noted to be associated with systemic diseases including diabetes and chronic renal failure. In previous smaller retrospe
Externí odkaz:
https://doaj.org/article/4332e79714e149bda622cdc473537f4a
Autor:
Danielle M.M. Harris, Silke Szymczak, Sven Schuchardt, Johannes Labrenz, Florian Tran, Lina Welz, Hanna Graßhoff, Henner Zirpel, Melike Sümbül, Mhmd Oumari, Nils Engelbogen, Ralf Junker, Claudio Conrad, Diamant Thaçi, Norbert Frey, Andre Franke, Stephan Weidinger, Bimba Hoyer, Philip Rosenstiel, Silvio Waschina, Stefan Schreiber, Konrad Aden
Publikováno v:
EBioMedicine, Vol 102, Iss , Pp 105056- (2024)
Summary: Background: Chronic inflammatory diseases (CIDs) are systems disorders that affect diverse organs including the intestine, joints and skin. The essential amino acid tryptophan (Trp) can be broken down to various bioactive derivatives importa
Externí odkaz:
https://doaj.org/article/dec1a5c50cfb47d881f49ff39ebb0105
Autor:
Michael J. Cork, Diamant Thaçi, Lawrence F. Eichenfield, Peter D. Arkwright, Zhen Chen, Ryan B. Thomas, Matthew P. Kosloski, Ariane Dubost-Brama, Randy Prescilla, Ashish Bansal, Noah A. Levit
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 11, Pp 2697-2719 (2023)
Abstract Background For children aged 6–11 years with uncontrolled severe atopic dermatitis (AD), 16 weeks of treatment with dupilumab resulted in substantial clinical benefit compared with placebo with an acceptable safety profile. However, longer
Externí odkaz:
https://doaj.org/article/4dab87121bb04ebfa5a3e58c15eea599
Autor:
Diamant Thaçi, Christos Tziotzios, Taisuke Ito, Justin Ko, Ayşe Serap Karadağ, Hong Fang, Roger A. Edwards, Gianluca Bonfanti, Robert Wolk, Helen Tran, Ernest Law
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 11, Pp 2621-2634 (2023)
Abstract Introduction Ritlecitinib demonstrated efficacy in patients with alopecia areata (AA) in the ALLEGRO phase 2b/3 study (NCT03732807). However, hair loss presentation may vary based on location (e.g., scalp, eyebrow/eyelash, body). Here, we so
Externí odkaz:
https://doaj.org/article/e5c03365e4f84cdf8ff6a93badf73fd5
Publikováno v:
Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)
Background Five-year tildrakizumab safety data have been reported as exposure-adjusted incidence rates (EAIRs) of patients with events per 100 patient-years (PYs) of exposure. Objectives To present 5-year safety data from reSURFACE 1/2 phase 3 trials
Externí odkaz:
https://doaj.org/article/c4b92278d4af48e2a8cee67af1d1b83c
Autor:
Thomas Bieber, Norito Katoh, Eric L. Simpson, Marjolein de Bruin-Weller, Diamant Thaçi, Antonio Torrelo, Angelina Sontag, Susanne Grond, Maher Issa, Xiaoyu Lu, Tracy Cardillo, Katrin Holzwarth, Jacob P. Thyssen
Publikováno v:
Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)
Background Baricitinib, a selective Janus kinase (JAK)1/JAK2 inhibitor, is approved for treatment of moderate-to-severe atopic dermatitis (AD) in adults. Objectives We report integrated baricitinib safety data in patients with up to 3.9-years exposur
Externí odkaz:
https://doaj.org/article/ca9ed6e40be942ef9798f73046c71ec1
Autor:
Matthias Augustin, Andrea Bauer, Konstantin Ertner, Ralph von Kiedrowski, Florian Schenck, Jutta Ramaker-Brunke, Sophie Möller, Anja Fait, Mike Bastian, Diamant Thaçi
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 3, Pp 803-816 (2023)
Abstract Introduction Dupilumab has significantly improved the signs, symptoms and quality of life (QoL) of patients with moderate-to-severe atopic dermatitis (AD) in randomised, controlled clinical trials. However, there is a need to assess the effe
Externí odkaz:
https://doaj.org/article/6709c8efa6eb48a8b6a6220b730780b3
Autor:
Frank Behrens, Jürgen Rech, Jürgen Braun, Denis Poddubnyy, Gerd R Burmester, Uta Kiltz, Stephanie Finzel, Diamant Thaçi, Herbert Kellner, Karolina Benesova, Reinhard E Voll, Jan Brandt, Andrea Rubbert-Roth, David M Kofler, Klaus Krüger, Siegfried Wassenberg, Winfried Demary, Regina Max, Peter Kastner, Michaela Koehm, Ulrich von Hinüber, Raoul Bergner, Jan Brandt-Jürgens, Ann C Foldenauer, Tanja Rossmanith, Maren Sieburg, Rieke HE Alten, Arnd Kleye, David Kofler, Gabriele Lorenz, Holger Schwenke, Astrid Thiele, Jochen Walter
Publikováno v:
RMD Open, Vol 9, Iss 4 (2023)
Background The influence of sex on treatment outcomes during interleukin-12/23 therapy in patients with psoriatic arthritis (PsA) has not been explored.Objective To conduct exploratory post hoc analyses of sex-stratified data from the MUST trial, an
Externí odkaz:
https://doaj.org/article/b3acb669834f448d9e33b145ffe10884